Biosig Technologies Inc logo

BSGM - Biosig Technologies Inc Share Price

$4.57 0.1  2.0%

Last Trade - 09/04/21

Small Cap
Market Cap £106.0m
Enterprise Value £86.0m
Revenue £n/a
Position in Universe 4849th / 6827
Unlock BSGM Revenue
Relative Strength (%)
1m -1.48%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -63.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 3.99 17.2
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BioSigTechnologies Inc revenues was not reported. Net lossapplicable to common stockholders increased 53% to $52.2M.Higher net loss reflects Stock-based Compensation in SGAincrease of 72% to $23.9M (expense), Research anddevelopment - Balancing va increase from $7.8M to $16.9M(expense), General and administrative - Balancing vincrease of 57% to $17M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BSGM
Graphical History


BSGM Revenue Unlock BSGM Revenue

Net Income

BSGM Net Income Unlock BSGM Revenue

Normalised EPS

BSGM Normalised EPS Unlock BSGM Revenue

PE Ratio Range

BSGM PE Ratio Range Unlock BSGM Revenue

Dividend Yield Range

BSGM Dividend Yield Range Unlock BSGM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BSGM EPS Forecasts Unlock BSGM Revenue
Profile Summary

BioSig Technologies, Inc. is a commercial-stage medical device company. The Company is commercializing biomedical signal processing technology platform to extract information from physiologic signals. The Company focuses on providing intracardiac signal information to electrophysiologists during electrophysiology (EP) studies and cardiac catheter ablation procedures for atrial fibrillation (AF) and ventricular tachycardia (VT). The Company is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. The PURE EP System is a signal acquisition and processing technology.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 21, 2011
Public Since September 22, 2014
No. of Shareholders: 279
No. of Employees: 49
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 31,789,781
Free Float (0.0%)
Eligible for
BSGM Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BSGM
Upcoming Events for BSGM
Monday 12th April, 2021
Biosig Technologies Inc Present at Needham Healthcare Conference (Virtual)
Frequently Asked Questions for Biosig Technologies Inc
What is the Biosig Technologies Inc share price?

As of 09/04/21, shares in Biosig Technologies Inc are trading at $4.57, giving the company a market capitalisation of £106.0m. This share price information is delayed by 15 minutes.

How has the Biosig Technologies Inc share price performed this year?

Shares in Biosig Technologies Inc are currently trading at $4.57 and the price has moved by -11.61% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosig Technologies Inc price has moved by -40.42% over the past year.

What are the analyst and broker recommendations for Biosig Technologies Inc?

Of the analysts with advisory recommendations for Biosig Technologies Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Biosig Technologies Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Biosig Technologies Inc next release its financial results?

Biosig Technologies Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Biosig Technologies Inc dividend yield?

Biosig Technologies Inc does not currently pay a dividend.

Does Biosig Technologies Inc pay a dividend?

Biosig Technologies Inc does not currently pay a dividend.

When does Biosig Technologies Inc next pay dividends?

Biosig Technologies Inc does not currently pay a dividend.

How do I buy Biosig Technologies Inc shares?

To buy shares in Biosig Technologies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biosig Technologies Inc?

Shares in Biosig Technologies Inc are currently trading at $4.57, giving the company a market capitalisation of £106.0m.

Where are Biosig Technologies Inc shares listed? Where are Biosig Technologies Inc shares listed?

Here are the trading details for Biosig Technologies Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: BSGM
What kind of share is Biosig Technologies Inc?

Based on an overall assessment of its quality, value and momentum, Biosig Technologies Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Biosig Technologies Inc share price forecast 2021?

Shares in Biosig Technologies Inc are currently priced at $4.57. At that level they are trading at 0.184% discount to the analyst consensus target price of 0.00.

Analysts covering Biosig Technologies Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.58 for the next financial year.

How can I tell whether the Biosig Technologies Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosig Technologies Inc. Over the past six months, the relative strength of its shares against the market has been -27%. At the current price of $4.57, shares in Biosig Technologies Inc are trading at -17.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biosig Technologies Inc PE Ratio?

We were not able to find PE ratio data for Biosig Technologies Inc.

Who are the key directors of Biosig Technologies Inc?

Biosig Technologies Inc's management team is headed by:

Kenneth Londoner - CHM
Jeffrey O'Donnell - LED
Patrick Gallagher - IND
Steven Chaussy - CFO
Donald Foley - IND
Andrew Filler - IND
John Kowalski - VPR
Manasi Patwardhan - OTH
Olivier Chaudoir - DMK
Julie Stephenson - VPR
Andrew Ballou - VPR
Anthony Zook - DRC
Who are the major shareholders of Biosig Technologies Inc?

Here are the top five shareholders of Biosig Technologies Inc based on the size of their shareholding:

Londoner (Kenneth L) Individual Investor
Percentage owned: 8.89% (2.83m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.99% (1.59m shares)
Mikolaitis (Lora) Individual Investor
Percentage owned: 3.99% (1.27m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.74% (1.19m shares)
Chaussy (Steven) Individual Investor
Percentage owned: 2.61% (830k shares)
Similar to BSGM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.